Abstract: Pentobarbital (PB) and ketamine (Ket) influence the concentration of neurotransmitters in the brain. PB has been reported to decrease the extracellular nitric oxide (NO) concentration through a decrease in acetylcholine (ACh) release, while Ket has been shown to increase the NO concentration via an increase in ACh release. Here, we investigated effects of PB and Ket on NO release and the relationship between NO and ACh in the rat striatum by in vivo microdialysis experiments. Male Sprague-Dawley rats were used. A microdialysis probe was inserted into the right striatum and perfused with modified Ringer's solution. Samples were collected every 15 min and injected into an HPLC system. The rats were freely moving, and PB and Ket were administered intraperitoneally. Neostigmine (1 and 10 µM) and mecamylamine (100 µM) were added to the perfusate. Calcium and magnesium concentrations were modified for each anesthetic to influence ACh release. PB decreased NO products (NOx) while Ket increased them. While perfusion with neostigmine showed no effect on baseline NOx concentrations, it diminished the PB-induced NOx reduction at low concentrations and abolished it at high concentrations. Magnesium-free perfusion had no effect on baseline NOx concentrations, whereas perfusion at a low magnesium concentration antagonized the PB-induced NOx reduction. Mecamylamine and calcium-free perfusion had no effect on baseline NOx concentrations and Ket-induced NOx increases. PB may decrease NO release through reduction in ACh release, whereas Ket may increase NO release independent of ACh regulation.
Introduction
two intravenous anesthetics, pentobarbital (PB) and ketamine (Ket), have been among the most popular hypnotic agents utilized in animal experiments [8, 21] . Numerous in vivo laboratory studies concerning neuroscience have been conducted under general anesthesia [10] [11] [12] because of the ethical limitations at almost all institutions [20] . however, one of the primary concerns of anesthesiologists is the actual change induced by general anesthesia itself because anesthetics may induce various changes in neuronal activity and neural transmission, including concentrations of neurotransmitters in the brain [7, 19] . Studies involving free-moving microdialysis can determine extracellular concentrations of neurotransmitters [norepinephrine, dopamine (da), serotonin, and histamine] before, during, and after anesthesia [2, 5, 17] .
our own preliminary investigation involving in vivo microdialysis experiments [5] demonstrated that PB decreased the extracellular da concentration in the rat striatum, a decrease that could be explained as a result of changes in nitric oxide (No) release [14] . more recently, we found reduced concentrations of oxidative products of No (Nox) during PB-induced general anesthesia [1] and speculated that this effect might be a result of inhibition of acetylcholine (ach) release. No has been identified as an important neurotransmitter responsible for interneuronal communication without synaptic communication [13] . Unlike ion channels or definite synaptic connections such as neuromuscular junctions, interneuronal signal transmission by No requires no specific receptor. NO easily diffuses into the extracellular space as a gas and permeates into the cytoplasm [13, 14] , modulating release and reuptake of numerous neurotransmitters into the central nervous system [14] .
in the brain, ach plays an important role in No homeostasis [24] . No likewise regulates ach release [15] , establishing a feedback loop. Exposure to PB-induced general anesthesia could further modulate the feedback loop, including that for ach release, and regulate the extracellular No concentration. Similarly, another popular intravenous anesthetic, Ket, has been reported to increase the No concentration via an increase in ach release in the brain [25] . however, PB and Ket showed differential effects on ach release in the striatum [18] . therefore, in the present study, we used in vivo microdialysis experiments to study the effects of PB and Ket on No release and the relationship between ach and No in the rat striatum.
Materials and Methods
the study protocol was approved by the animal investigation committee of hamamatsu university School of medicine (hamamatsu, Japan). the microdialysis technique in freely moving rats was performed as described previously [2, 4, 5] . adult male Sprague-dawley rats (each n=6-8, 7-8 weeks old, weighing 280-320 g, Japan SLc, hamamatsu, Japan) were anesthetized with 5% sevoflurane. The rats voluntarily inhaled the anesthetic agent and were then placed in a stereotaxic apparatus (Sr-6r, Narisige co., Ltd., tokyo, Japan). a guide cannula (aG-8-3, Eicom, Kyoto, Japan) was stereotaxically implanted just above the striatum (aP, +0.6 mm; ML, +3.0 mm; DV, −3.8 mm) following the atlas of Paxinos and watson [16] . the rats were allowed to recover for at least 2 days before the experiment began and to access water and food freely. after each experiment, the rats were sacrificed by excess inhalation of enflurane. The brain was removed and frozen. Thus, the section of brain was investigated, and the location of the microdialysis probe was determined histologically. microdialysis probes were obtained from Eicom (o.d. 0.22 mm, membrane length 3 mm, polycarbonate tubing, cut-off molecular weight 50,000). on the day of the experiment, the rats were briefly anesthetized with sevoflurane. The microdialysis probe was inserted carefully in the striatum through the guide cannula and fixed to the cannula using a screw. this procedure was performed within 3 min of anesthesia. the rats were then placed in a clear open polycarbonate box for recovery. the rats regained consciousness within approximately 3 min. after recovery, the microdialysis probe was continuously perfused with modified Ringer's solution (147 mEq L −1 Na + , 3.0 mEq L −1 K + , 2.6 mEq L −1 ca 2+ , 2.0 mEq L −1 mg 2+ , 155 mEq L −1 cl − ) at a flow rate of 2 ml min −1 using a microinfusion pump (cma/102, carnegie medicine, Stockholm, Sweden).
after 2 h of dialysis equilibration, the dialysate was collected every 15 min in an automated sample injector connected to an online No detector-hPLc-spectrophotometer system (ENo-20, Eicom). No 2 − and No 3 − were separated using a reverse-phase separation column packed with polystyrene polymer (No-PaK, 4.6 × 50 mm, Eicom). No 3 − was reduced to No 2 − in a reduction column packed with copper-plated cadmium filings (NOrEd, Eicom). No 2 − was mixed with Griess reagent to form a purple azo dye in a reaction coil, and the absorbance of the dye product at 540 nm was measured using a spectrophotometer. the quantity of No 2 − and No 3 − was determined and recorded on a personal computer using a customized software (Powerchrom, adinstruments Pty Ltd., NSw, australia). Nox was the sum of No 2 − and No 3 − . the mean concentration of the last three samples obtained before pharmacological interventions was used as the baseline concentration (run of hPLc sequence 1, 2, and 3). data were analyzed by one-way analysis of variance using the drug as the between-subjects variable for each fraction. a subsequent Newman-Keuls post hoc multiple comparison test (NcSS 2000, Number cruncher Statistical Systems, Kaysville, ut, uSa) was performed to determine significant drug interactions (P<0.05).
PB and Ket were purchased from takeda Pharmaceutical, osaka, Japan, and daiichi Sankyo co., Ltd., tokyo, Japan, respectively. Neostigmine and mecamylamine were obtained from Sigma-aldrich (St. Louis, mo, uSa).
the rats were able to move freely and PB (25 and 75 mg kg −1 ) and Ket (30 and 100 mg kg −1 ) were administered intraperitoneally. Neostigmine (1 and 10 µm) and mecamylamine (100 µm) were added to the perfusate from the end of run 3. the concentrations of calcium and magnesium were modified for each anesthetic to influence ach release from the end of run 3. the magnesium concentrations of the dialysate for PB were 1 (half) and 0 mEq l −1 compared with those of the modified Ringer's solution. the magnesium concentration of dialysate for Ket was twofold (4 mEq l −1 ) that of the Ringer's solution.
Results
Both anesthetics induced anesthesia approximately 30 min with a low dose and 60 min with a high dose. PB decreased Nox in a dose-dependent manner (Fig. 1a) . Perfusion with neostigmine both 1 and 10 µm of neostigmine showed no effect on the baseline Nox concentration compared with the control group (Fig. 1b) . Perfusion with neostigmine at a low concentration (1 µm) diminished PB-induced Nox reduction, and perfusion at a high concentration (10 µm) abolished it (Fig. 1c) . magnesium-free perfusion showed no effect on the base- line Nox concentration (Fig. 1d) , whereas perfusion at a low magnesium concentration antagonized the PBinduced Nox reduction (Fig. 1d) . Ketamine increased Nox in a dose-dependent manner (Fig. 2a) . mecamylamine is an inhibitor of nicotinic ach receptor. mecamylamine (Fig. 2b) and calcium-free perfusion (Fig. 2c ) had no effect on the baseline Nox concentration. Both perfusion with mecamylamine and calcium-free perfusion failed to modify the Ket-induced Nox increase (Fig. 2 and 2c ).
Discussion
the extracellular Nox concentration was decreased by PB administration, and the effect was antagonized by neostigmine and magnesium-free perfusion. conversely, Ket administration increased Nox, and the effect was not influenced by mecamylamine and calcium-free perfusion with a high level of magnesium.
Neostigmine is an inhibitor of ach esterase and increases the extracellular ach concentration [15] . Extracellular magnesium ion inhibits ach release at an axon terminal [22, 23] . Both neostigmine and magnesium-free perfusion showed no significant effect on the baseline Nox concentration in the present study. however, the pharmacological manipulations demonstrated an antagonistic effect on PB-induced Nox reduction. in the central nervous system, homeostatic regulation of ach tends to be strictly maintained, and the concentration of neurotransmitters in the extracellular space might be not altered by such minor pharmacological treatments without anesthesia. other contents of amino acids, e.g., dopamine, in the brain are not influenced by magnesium [23] despite a potent antagonizing effect on ach release. Previous results [23] are consistent with changes in No concentration observed in the present study. administration of PB not only inhibited No release but also impeded ach-No homeostasis. thus, the PB-induced No reduction would be antagonized by the increase in ach concentration induced by neostigmine and magnesiumfree perfusion.
Sato et al. [18] demonstrated a Ket-induced Nox increase and explained that Ket might enhance ach release and induce subsequent No production. however, the exact mechanism of action of ach on No regulation in the brain has remained uncertain. in the rat hippocampus, Ket increases ACh release [18] , whereas it fails to influence ach release in the striatum [18] . on the other hand, PB decreases ach release in both the hippocampus and striatum [18] . although wu et al. [25] explained the PB-induced decrease and Ket-induced increase in No release as a result of the change that occurs in ach release in both the hippocampus and striatum, the conclusions were tenuous, especially those related to the striatum.
regarding arterial vessels, ach is known to release No from the endothelium, and No has actually been found as an endothelium-dependent relaxing factor. in the brain, ach has the potential to increase No production by activating neuronal No synthetase. the effect of anesthetics on the brain remains highly complex, and both ach and No may have an important role in synaptic communication. the neuronal form of No synthetase is widely distributed in the central nervous system and reportedly produces No primarily in response to activation of N-methyl-d-aspartate (Nmda) receptors stimulated by glutamate [6] . the results of the present study demonstrated that mecamylamine and calcium-free perfusion had no effect on Ket-induced No release. mecamylamine inhibits activation of ach receptors in the brain, and vesicular release of ach from the axon terminal is dependent on calcium concentration. mecamylamine and calcium-free perfusion showed no effect on the baseline Nox concentration. these results were similar to those of neostigmine and magnesium-free perfusion. the ach concentration may not change despite of pharmacological treatment because of restrictive homeostasis in the brain. however, mecamylamine and calcium-free perfusion also failed to modify Ket-induced No release. Ket-induced No release is independent of cholinergic regulation. Ket is a well-known Nmda receptor antagonist, so one possible explanation is that Ket directly activates pathways of No synthesis without increasing glutamate release or Nmda receptor activation.
in our previous study [5] , PB decreased the extracellular da concentration in the rat striatum. this extracellular da concentration is regulated by a da transporter (dat). reuptake of da from the extracellular space into the cytoplasm via dat is modulated by No [9] , and No inhibits da uptake. reduction in PB-induced No release might be followed by enhanced da uptake and by decreased extracellular da concentration. the negative feedback loop introduced by Kiss et al. [14] clearly explains the effect of PB on da release through No modulation.
Volatile anesthetics such as halothane showed no effect on the extracellular da concentration, whereas the extracellular concentration of da metabolites increased in the rat striatum during anesthesia [2, 3] . halothane anesthesia enhanced methamphetamine-or nomifensineinduced da release. another volatile anesthetic, sevoflurane, decreased NO release as observed with PB in our study. General anesthesia with volatile anesthetics and typical intravenous anesthetics such as PB inhibit ach and No release, and a reduction in the extracellular No concentration might be followed by reuptake of neurotransmitters, including da. the unique property of Ket as a general anesthetic might be explained by its effect on No release.
the in vivo microdialysis experiments have a series of technical limitations themselves unlike in vitro investigations. the actual concentration or amount of nitric oxide products in the brain could not be measured because the rate of recovery of neurotransmitters in perfusate from the extracellular space into a dialyzing probe through the membrane is not predetermined. alternations in recovery or No release might have occurred throughout the study, and consistent increases were found in every experiment, as found in a previous investigation [25] ; however, we could not explain the reason for stable intraday changes. in summary, Ket increased No release in the rat striatum. unlike PB, cholinergic inhibition showed no effect on Ket-induced No release. Ket might directly activate No synthetase in the rat brain striatum.
